GlassScriptPhysician profile
Kanesha L Bryant
NPI 1609037662
$764.14
in general payments reported to CMS, 2019-2025
10 companies · $14.65 in 2025
The $14.65 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2021: $41.90 · 2022: $25.47 · 2023: $424 · 2024: $132 · 2025: $14.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $480.04 | 2022-2024 | Myrisk |
| Medtronic USA, INC. | $63.85 | 2019 | |
| Focal Therapeutics, INC. | $43.31 | 2019 | |
| Mentor Worldwide LLC | $41.90 | 2021 | |
| Merck Sharp & Dohme LLC | $35.17 | 2024-2025 | Keytruda |
| Lilly USA, LLC | $26.20 | 2024 | Verzenio |
| Molli Surgical (US) INC | $25.99 | 2023 | |
| Bard Peripheral Vascular, INC. | $19.06 | 2019 | |
| Seagen INC. | $15.23 | 2023 | Tukysa |
| Astrazeneca Pharmaceuticals LP | $13.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanesha Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.